Molecular Therapy: Oncolytics (Mar 2022)

Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting desmocollin-2

  • Wenjuan Yang,
  • Shiming Tan,
  • Lixia Yang,
  • Xiaohui Chen,
  • Ruiqian Yang,
  • Linda Oyang,
  • Jinguan Lin,
  • Longzheng Xia,
  • Nayiyuan Wu,
  • Yaqian Han,
  • Yanyan Tang,
  • Min Su,
  • Xia Luo,
  • Yiqing Yang,
  • Lisheng Huang,
  • Zifan Hu,
  • Yi Tao,
  • Lin Liu,
  • Yi Jin,
  • Hui Wang,
  • Qianjin Liao,
  • Yujuan Zhou

Journal volume & issue
Vol. 24
pp. 612 – 623

Abstract

Read online

The aim of this study was to investigate whether and how exosomal miR-205-5p regulated angiogenesis and nasopharyngeal carcinoma (NPC) metastasis. We found that up-regulated serum exosomal miR-205-5p levels were associated with NPC progression and worse overall survival of NPC patients. miR-205-5p over-expression significantly increased tube formation, wound healing, migration and invasion of NPC cells, and lung metastasis of NPC tumors, whereas miR-205-5p inhibition had opposite effects. Exosomal miR-205-5p from NPC cells promoted the migration, tube formation, and microvessel density (MVD) of HUVECs in vitro and in vivo. Furthermore, bioinformatics-, luciferase reporter-, and biotinylated miR-205-5p-based pull-down assays indicated that miR-205-5p directly bound to the 3′ UTR of desmocollin-2 (DSC2). Exosomal miR-205-5p targeted DSC2 to enhance the EGFR/ERK signaling and MMP2/MMP9 expression, promoting angiogenesis and NPC metastasis, which was abrogated by DSC2 over-expression. Finally, the levels of miR-205-5p transcripts were positively correlated with MVD but negatively with DSC2 expression in NPC tissues, and patients with miR-205high/DSC2low NPC had worse overall survival. In conclusion, exosomal miR-205-5p promotes angiogenesis and NPC metastasis by targeting DSC2 to enhance EGFR/ERK signaling and MMP expression. This exosomal/miR-205-5p/EGFR/ERK axis may be a new therapeutic target for intervention of NPC metastasis.

Keywords